News and Press Releases

Groundbreaking health research gets £7.6m boost as Academy of Medical Sciences funds emerging scientific leaders 

7 April 2025 -- London, UK -- In its largest-ever funding initiative for early-career researchers, the Academy of Medical Sciences is investing £7.6 million to tackle urgent health challenges from...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 7, 2025

41 Portland Pl, London W1B 1QH

HUTCHMED Announces that TAGRISSO plus ORPATHYS demonstrated high,clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial

New data demonstrate efficacy for the oral treatment combination to address MET-driven resistance in EGFR-mutated lung cancer MET is a common biomarker in this setting for patients who develop resistance...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 16, 2024

Agreement to Explore Optimer Vehicles for Targeted Delivery of siRNA

New Collaboration to Evaluate Aptamer's Fibrotic Liver Delivery Vehicles with siRNA 3 July 2024, York, England - Aptamer Group plc (AIM: APTA), the developer of novel Optimer binders to enable...

Category: Drug Delivery
Posted: July 3, 2024

Aptamer group, Suite 2.80 – 2.87, Bio Centre, Innovation Way, Heslington, York, YO10 5NY

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care

The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science 18 October 2023 -- Boston, US and Rolle, Switzerland --...

Category: Biotechnology
Posted: October 19, 2023

La Pièce 12, CH-1180 Rolle, Switzerland

AstraZeneca reinforces commitment to protecting the most vulnerable from serious infectious diseases at IDWeek 2023

Real-world data from INFORM study demonstrate increased risk of severe COVID-19 outcomes among all individuals with immunocompromising conditions and highlight need for additional protection FluMist Quadrivalent data support the potential...

Category: Clinical Trials
Posted: October 12, 2023

PLC 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA UK